Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;182:257-263.
doi: 10.1016/j.actatropica.2018.03.009. Epub 2018 Mar 15.

Current Status, Challenges and Perspectives in the Development of Vaccines Against Yellow Fever, Dengue, Zika and Chikungunya Viruses

Affiliations
Review

Current Status, Challenges and Perspectives in the Development of Vaccines Against Yellow Fever, Dengue, Zika and Chikungunya Viruses

José V J Silva Jr et al. Acta Trop. .

Abstract

Emerging and re-emerging viral infections transmitted by insect vectors (arthopode-borne viruses, arbovirus) are a serious threat to global public health. Among them, yellow fever (YFV), dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses are particularly important in tropical and subtropical regions. Although vector control is one of the most used prophylactic measures against arboviruses, it often faces obstacles, such as vector diversity, uncontrolled urbanization and increasing resistance to insecticides. In this context, vaccines may be the best control strategy for arboviral diseases. Here, we provide a general overview about licensed vaccines and the most advanced vaccine candidates against YFV, DENV, CHIKV and ZIKV. In particular, we highlight vaccine difficulties, the current status of the most advanced strategies and discuss how the molecular characteristics of each virus can influence the choice of the different vaccine formulations.

Keywords: Arboviruses; Disease control; Public health; Vaccination.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback